InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

FRACTYL HEALTH, INC.

GUTS Clue Score22
United States Fiscal year ends December CIK 0001572616
$4.42 +4.49% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.42 +215.71% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 2 Feb 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2023Revenue0.1Operating income−50.8Net income−77.1EPS, diluted−45.29Fiscal year 2024Revenue0.1 −22.5%Operating income−93.5Net income−68.7EPS, diluted−1.62Fiscal year 2025Revenue0.0 −100.0%Operating income−96.8Net income−141.0EPS, diluted−1.86
FY2023FY2024FY2025
Revenue 0.1 0.1 0.0
Growth −22.5% −100.0%
Operating income −50.8 −93.5 −96.8
Net income −77.1 −68.7 −141.0
Growth
EPS, diluted −45.29 −1.62 −1.86

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2023Gross margin35.8%Operating margin−42,363.3%Net margin−64,242.5%Free cash flow margin−35,985.0%Fiscal year 2024Gross margin46.2%Operating margin−100,571.0%Net margin−73,864.5%Free cash flow margin−72,350.5%Fiscal year 2025
FY2023FY2024FY2025
Gross margin 35.8% 46.2% n/a
Operating margin −42,363.3% −100,571.0% n/a
Net margin −64,242.5% −73,864.5% n/a
Free cash flow margin −35,985.0% −72,350.5% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2023Operating cash flow−42.8Capital expenditure−0.4Free cash flow−43.2Fiscal year 2024Operating cash flow−65.5Capital expenditure−1.8Free cash flow−67.3Fiscal year 2025Operating cash flow−90.3Capital expenditure−0.6Free cash flow−90.9
FY2023FY2024FY2025
Operating cash flow −42.8 −65.5 −90.3
Capital expenditure −0.4 −1.8 −0.6
Free cash flow −43.2 −67.3 −90.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2023Cash33.2Shareholders’ equity−325.1Fiscal year 2024Cash67.5Shareholders’ equity28.4Fiscal year 2025Cash81.5Shareholders’ equity9.5
FY2023FY2024FY2025
Cash 33.2 67.5 81.5
Shareholders’ equity −325.1 28.4 9.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
35.8% 46.2% n/a
−42,363.3% −100,571.0% n/a
−64,242.5% −73,864.5% n/a
−35,985.0% −72,350.5% n/a
Spending
31,698.3% 75,775.3% n/a
10,700.8% 24,841.9% n/a
299.2% 1,897.8% n/a
Returns
n/a −241.7% −1,490.3%
−101.2% −63.6% −116.1%
Balance and payout
149.5% 73.7% 92.2%